Suk‐Jae Chung

5.8k citations
151 papers · 5.0k indexed · 1 hit paper · h-index 35
Topics
Drug Transport and Resistance Mechanisms (53 papers)Advanced Drug Delivery Systems (19 papers)Pharmacogenetics and Drug Metabolism (18 papers)

In The Last Decade

Suk‐Jae Chung

150 papers receiving 4.9k citations

Hit Papers

Thioredoxin-dependent peroxide reductase from yeast.19942026200420151994250500750

Peers

Suk‐Jae Chung
Comparison fields: 5 of 134
  • Molecular Biology 2.0k
  • Pharmaceutical Science 1.3k
  • Biomaterials 992
  • Oncology 777
  • Biomedical Engineering 457
Replace Ramakrishna Sistla with:
Ramakrishna Sistla India
Chang‐Koo Shim South Korea
In‐Soo Yoon South Korea
Vincent H.L. Lee United States
Kazutaka Higaki Japan
Zhonggui He China
Chandraiah Godugu India
V.G.M. Naidu India
Émilie Viennois United States
Johan Karlsson Sweden
Suk‐Jae Chung relative to Ramakrishna Sistla India Ramakrishna Sistla's profile →
Citations per field
00.5×1.5×
Ramakrishna Sistla · 1×
Citations per year

Countries citing papers authored by Suk‐Jae Chung

Since Specialization
Citations

This map shows the geographic impact of Suk‐Jae Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suk‐Jae Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suk‐Jae Chung more than expected).

Fields of papers citing papers by Suk‐Jae Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suk‐Jae Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suk‐Jae Chung. The network helps show where Suk‐Jae Chung may publish in the future.

Co-authorship network of co-authors of Suk‐Jae Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Suk‐Jae Chung. A scholar is included among the top collaborators of Suk‐Jae Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suk‐Jae Chung. Suk‐Jae Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 16
5 11
6 11
7 6
8 9
9 99
10 29
11 70
12 2
13 3
14 7
15 112
16 2
17 11
18 23
19 14
20 33

About Suk‐Jae Chung

Suk‐Jae Chung is a scholar working on Pharmaceutical Science, Pharmacology and Oncology, having authored 151 papers that have together received 5.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (53 papers), Advanced Drug Delivery Systems (19 papers) and Pharmacogenetics and Drug Metabolism (18 papers). The work is most often cited by research in Pharmaceutical Science (1.3k citations), Biomaterials (992 citations) and Pharmacology (386 citations). Suk‐Jae Chung has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Chang‐Koo Shim, Dae‐Duk Kim, Ho Zoon Chae, Sue Goo Rhee, Hyun‐Jong Cho, Fude Cui, H L Fung, Jung‐Sun Kim, Keon‐Hyoung Song and Saeho Chong. Their work appears in journals such as Journal of Biological Chemistry, Biomaterials and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026